Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG)
Titel:
Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG)
Auteur:
Kotsakis, A. Kentepozidis, N. Emmanouilidis, Ch. Polyzos, A. Agelidou, A. Vaslamatzis, M. Chandrinos, V. Agelaki, S. Vamvakas, L. Kalbakis, K. Katsaounis, P. Stoltidis, D. Nintos, G. Hatzidaki, D. Vetsika, E.K. Mavroudis, D. Georgoulias, V.